Amifampridine Market, Global Outlook and Forecast 2022-2028
Amifampridine (pyridine-3,4-diamine, 3,4-diaminopyridine, 3,4-DAP) is used as a drug, predominantly in the treatment of a number of rare muscle diseases. The free base form of the drug has been used to treat congenital myasthenic syndromes and Lambert–Eaton myasthenic syndrome (LEMS) through compassionate use programs since the 1990s and was recommended as a first line treatment for LEMS in 2006, using ad hoc forms of the drug, since there was no marketed form
This report contains market size and forecasts of Amifampridine in global, including the following market information:
Global Amifampridine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Amifampridine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Amifampridine companies in 2021 (%)
The global Amifampridine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Generic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Amifampridine include Jacobus Pharmaceutical, Unichem, BioMarin Pharmaceutical, Wockhardt, Glenmark Pharmaceuticals, Norris Pharm, BLD Pharm, Biosynth AG and Innovapharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Amifampridine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amifampridine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Amifampridine Market Segment Percentages, by Type, 2021 (%)
Global Amifampridine Market Segment Percentages, by Application, 2021 (%)
Global Amifampridine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Amifampridine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Amifampridine revenues share in global market, 2021 (%)
Key companies Amifampridine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Amifampridine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Amifampridine in global, including the following market information:
Global Amifampridine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Amifampridine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Amifampridine companies in 2021 (%)
The global Amifampridine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Generic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Amifampridine include Jacobus Pharmaceutical, Unichem, BioMarin Pharmaceutical, Wockhardt, Glenmark Pharmaceuticals, Norris Pharm, BLD Pharm, Biosynth AG and Innovapharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Amifampridine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amifampridine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Amifampridine Market Segment Percentages, by Type, 2021 (%)
- Generic
- Patent
Global Amifampridine Market Segment Percentages, by Application, 2021 (%)
- Myasthenia Gravis
- Potassium Channel Blocker
Global Amifampridine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Amifampridine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Amifampridine revenues share in global market, 2021 (%)
Key companies Amifampridine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Amifampridine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Jacobus Pharmaceutical
- Unichem
- BioMarin Pharmaceutical
- Wockhardt
- Glenmark Pharmaceuticals
- Norris Pharm
- BLD Pharm
- Biosynth AG
- Innovapharm
- Founder Pharma
- BroadPharm
- CSNpharm
- Merck
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Amifampridine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Amifampridine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL AMIFAMPRIDINE OVERALL MARKET SIZE
2.1 Global Amifampridine Market Size: 2021 VS 2028
2.2 Global Amifampridine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Amifampridine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Amifampridine Players in Global Market
3.2 Top Global Amifampridine Companies Ranked by Revenue
3.3 Global Amifampridine Revenue by Companies
3.4 Global Amifampridine Sales by Companies
3.5 Global Amifampridine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Amifampridine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Amifampridine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Amifampridine Players in Global Market
3.8.1 List of Global Tier 1 Amifampridine Companies
3.8.2 List of Global Tier 2 and Tier 3 Amifampridine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Amifampridine Market Size Markets, 2021 & 2028
4.1.2 Generic
4.1.3 Patent
4.2 By Type - Global Amifampridine Revenue & Forecasts
4.2.1 By Type - Global Amifampridine Revenue, 2017-2022
4.2.2 By Type - Global Amifampridine Revenue, 2023-2028
4.2.3 By Type - Global Amifampridine Revenue Market Share, 2017-2028
4.3 By Type - Global Amifampridine Sales & Forecasts
4.3.1 By Type - Global Amifampridine Sales, 2017-2022
4.3.2 By Type - Global Amifampridine Sales, 2023-2028
4.3.3 By Type - Global Amifampridine Sales Market Share, 2017-2028
4.4 By Type - Global Amifampridine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Amifampridine Market Size, 2021 & 2028
5.1.2 Myasthenia Gravis
5.1.3 Potassium Channel Blocker
5.2 By Application - Global Amifampridine Revenue & Forecasts
5.2.1 By Application - Global Amifampridine Revenue, 2017-2022
5.2.2 By Application - Global Amifampridine Revenue, 2023-2028
5.2.3 By Application - Global Amifampridine Revenue Market Share, 2017-2028
5.3 By Application - Global Amifampridine Sales & Forecasts
5.3.1 By Application - Global Amifampridine Sales, 2017-2022
5.3.2 By Application - Global Amifampridine Sales, 2023-2028
5.3.3 By Application - Global Amifampridine Sales Market Share, 2017-2028
5.4 By Application - Global Amifampridine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Amifampridine Market Size, 2021 & 2028
6.2 By Region - Global Amifampridine Revenue & Forecasts
6.2.1 By Region - Global Amifampridine Revenue, 2017-2022
6.2.2 By Region - Global Amifampridine Revenue, 2023-2028
6.2.3 By Region - Global Amifampridine Revenue Market Share, 2017-2028
6.3 By Region - Global Amifampridine Sales & Forecasts
6.3.1 By Region - Global Amifampridine Sales, 2017-2022
6.3.2 By Region - Global Amifampridine Sales, 2023-2028
6.3.3 By Region - Global Amifampridine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Amifampridine Revenue, 2017-2028
6.4.2 By Country - North America Amifampridine Sales, 2017-2028
6.4.3 US Amifampridine Market Size, 2017-2028
6.4.4 Canada Amifampridine Market Size, 2017-2028
6.4.5 Mexico Amifampridine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Amifampridine Revenue, 2017-2028
6.5.2 By Country - Europe Amifampridine Sales, 2017-2028
6.5.3 Germany Amifampridine Market Size, 2017-2028
6.5.4 France Amifampridine Market Size, 2017-2028
6.5.5 U.K. Amifampridine Market Size, 2017-2028
6.5.6 Italy Amifampridine Market Size, 2017-2028
6.5.7 Russia Amifampridine Market Size, 2017-2028
6.5.8 Nordic Countries Amifampridine Market Size, 2017-2028
6.5.9 Benelux Amifampridine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Amifampridine Revenue, 2017-2028
6.6.2 By Region - Asia Amifampridine Sales, 2017-2028
6.6.3 China Amifampridine Market Size, 2017-2028
6.6.4 Japan Amifampridine Market Size, 2017-2028
6.6.5 South Korea Amifampridine Market Size, 2017-2028
6.6.6 Southeast Asia Amifampridine Market Size, 2017-2028
6.6.7 India Amifampridine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Amifampridine Revenue, 2017-2028
6.7.2 By Country - South America Amifampridine Sales, 2017-2028
6.7.3 Brazil Amifampridine Market Size, 2017-2028
6.7.4 Argentina Amifampridine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Amifampridine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Amifampridine Sales, 2017-2028
6.8.3 Turkey Amifampridine Market Size, 2017-2028
6.8.4 Israel Amifampridine Market Size, 2017-2028
6.8.5 Saudi Arabia Amifampridine Market Size, 2017-2028
6.8.6 UAE Amifampridine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Jacobus Pharmaceutical
7.1.1 Jacobus Pharmaceutical Corporate Summary
7.1.2 Jacobus Pharmaceutical Business Overview
7.1.3 Jacobus Pharmaceutical Amifampridine Major Product Offerings
7.1.4 Jacobus Pharmaceutical Amifampridine Sales and Revenue in Global (2017-2022)
7.1.5 Jacobus Pharmaceutical Key News
7.2 Unichem
7.2.1 Unichem Corporate Summary
7.2.2 Unichem Business Overview
7.2.3 Unichem Amifampridine Major Product Offerings
7.2.4 Unichem Amifampridine Sales and Revenue in Global (2017-2022)
7.2.5 Unichem Key News
7.3 BioMarin Pharmaceutical
7.3.1 BioMarin Pharmaceutical Corporate Summary
7.3.2 BioMarin Pharmaceutical Business Overview
7.3.3 BioMarin Pharmaceutical Amifampridine Major Product Offerings
7.3.4 BioMarin Pharmaceutical Amifampridine Sales and Revenue in Global (2017-2022)
7.3.5 BioMarin Pharmaceutical Key News
7.4 Wockhardt
7.4.1 Wockhardt Corporate Summary
7.4.2 Wockhardt Business Overview
7.4.3 Wockhardt Amifampridine Major Product Offerings
7.4.4 Wockhardt Amifampridine Sales and Revenue in Global (2017-2022)
7.4.5 Wockhardt Key News
7.5 Glenmark Pharmaceuticals
7.5.1 Glenmark Pharmaceuticals Corporate Summary
7.5.2 Glenmark Pharmaceuticals Business Overview
7.5.3 Glenmark Pharmaceuticals Amifampridine Major Product Offerings
7.5.4 Glenmark Pharmaceuticals Amifampridine Sales and Revenue in Global (2017-2022)
7.5.5 Glenmark Pharmaceuticals Key News
7.6 Norris Pharm
7.6.1 Norris Pharm Corporate Summary
7.6.2 Norris Pharm Business Overview
7.6.3 Norris Pharm Amifampridine Major Product Offerings
7.6.4 Norris Pharm Amifampridine Sales and Revenue in Global (2017-2022)
7.6.5 Norris Pharm Key News
7.7 BLD Pharm
7.7.1 BLD Pharm Corporate Summary
7.7.2 BLD Pharm Business Overview
7.7.3 BLD Pharm Amifampridine Major Product Offerings
7.7.4 BLD Pharm Amifampridine Sales and Revenue in Global (2017-2022)
7.7.5 BLD Pharm Key News
7.8 Biosynth AG
7.8.1 Biosynth AG Corporate Summary
7.8.2 Biosynth AG Business Overview
7.8.3 Biosynth AG Amifampridine Major Product Offerings
7.8.4 Biosynth AG Amifampridine Sales and Revenue in Global (2017-2022)
7.8.5 Biosynth AG Key News
7.9 Innovapharm
7.9.1 Innovapharm Corporate Summary
7.9.2 Innovapharm Business Overview
7.9.3 Innovapharm Amifampridine Major Product Offerings
7.9.4 Innovapharm Amifampridine Sales and Revenue in Global (2017-2022)
7.9.5 Innovapharm Key News
7.10 Founder Pharma
7.10.1 Founder Pharma Corporate Summary
7.10.2 Founder Pharma Business Overview
7.10.3 Founder Pharma Amifampridine Major Product Offerings
7.10.4 Founder Pharma Amifampridine Sales and Revenue in Global (2017-2022)
7.10.5 Founder Pharma Key News
7.11 BroadPharm
7.11.1 BroadPharm Corporate Summary
7.11.2 BroadPharm Amifampridine Business Overview
7.11.3 BroadPharm Amifampridine Major Product Offerings
7.11.4 BroadPharm Amifampridine Sales and Revenue in Global (2017-2022)
7.11.5 BroadPharm Key News
7.12 CSNpharm
7.12.1 CSNpharm Corporate Summary
7.12.2 CSNpharm Amifampridine Business Overview
7.12.3 CSNpharm Amifampridine Major Product Offerings
7.12.4 CSNpharm Amifampridine Sales and Revenue in Global (2017-2022)
7.12.5 CSNpharm Key News
7.13 Merck
7.13.1 Merck Corporate Summary
7.13.2 Merck Amifampridine Business Overview
7.13.3 Merck Amifampridine Major Product Offerings
7.13.4 Merck Amifampridine Sales and Revenue in Global (2017-2022)
7.13.5 Merck Key News
8 GLOBAL AMIFAMPRIDINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Amifampridine Production Capacity, 2017-2028
8.2 Amifampridine Production Capacity of Key Manufacturers in Global Market
8.3 Global Amifampridine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 AMIFAMPRIDINE SUPPLY CHAIN ANALYSIS
10.1 Amifampridine Industry Value Chain
10.2 Amifampridine Upstream Market
10.3 Amifampridine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Amifampridine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Amifampridine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Amifampridine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL AMIFAMPRIDINE OVERALL MARKET SIZE
2.1 Global Amifampridine Market Size: 2021 VS 2028
2.2 Global Amifampridine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Amifampridine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Amifampridine Players in Global Market
3.2 Top Global Amifampridine Companies Ranked by Revenue
3.3 Global Amifampridine Revenue by Companies
3.4 Global Amifampridine Sales by Companies
3.5 Global Amifampridine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Amifampridine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Amifampridine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Amifampridine Players in Global Market
3.8.1 List of Global Tier 1 Amifampridine Companies
3.8.2 List of Global Tier 2 and Tier 3 Amifampridine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Amifampridine Market Size Markets, 2021 & 2028
4.1.2 Generic
4.1.3 Patent
4.2 By Type - Global Amifampridine Revenue & Forecasts
4.2.1 By Type - Global Amifampridine Revenue, 2017-2022
4.2.2 By Type - Global Amifampridine Revenue, 2023-2028
4.2.3 By Type - Global Amifampridine Revenue Market Share, 2017-2028
4.3 By Type - Global Amifampridine Sales & Forecasts
4.3.1 By Type - Global Amifampridine Sales, 2017-2022
4.3.2 By Type - Global Amifampridine Sales, 2023-2028
4.3.3 By Type - Global Amifampridine Sales Market Share, 2017-2028
4.4 By Type - Global Amifampridine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Amifampridine Market Size, 2021 & 2028
5.1.2 Myasthenia Gravis
5.1.3 Potassium Channel Blocker
5.2 By Application - Global Amifampridine Revenue & Forecasts
5.2.1 By Application - Global Amifampridine Revenue, 2017-2022
5.2.2 By Application - Global Amifampridine Revenue, 2023-2028
5.2.3 By Application - Global Amifampridine Revenue Market Share, 2017-2028
5.3 By Application - Global Amifampridine Sales & Forecasts
5.3.1 By Application - Global Amifampridine Sales, 2017-2022
5.3.2 By Application - Global Amifampridine Sales, 2023-2028
5.3.3 By Application - Global Amifampridine Sales Market Share, 2017-2028
5.4 By Application - Global Amifampridine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Amifampridine Market Size, 2021 & 2028
6.2 By Region - Global Amifampridine Revenue & Forecasts
6.2.1 By Region - Global Amifampridine Revenue, 2017-2022
6.2.2 By Region - Global Amifampridine Revenue, 2023-2028
6.2.3 By Region - Global Amifampridine Revenue Market Share, 2017-2028
6.3 By Region - Global Amifampridine Sales & Forecasts
6.3.1 By Region - Global Amifampridine Sales, 2017-2022
6.3.2 By Region - Global Amifampridine Sales, 2023-2028
6.3.3 By Region - Global Amifampridine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Amifampridine Revenue, 2017-2028
6.4.2 By Country - North America Amifampridine Sales, 2017-2028
6.4.3 US Amifampridine Market Size, 2017-2028
6.4.4 Canada Amifampridine Market Size, 2017-2028
6.4.5 Mexico Amifampridine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Amifampridine Revenue, 2017-2028
6.5.2 By Country - Europe Amifampridine Sales, 2017-2028
6.5.3 Germany Amifampridine Market Size, 2017-2028
6.5.4 France Amifampridine Market Size, 2017-2028
6.5.5 U.K. Amifampridine Market Size, 2017-2028
6.5.6 Italy Amifampridine Market Size, 2017-2028
6.5.7 Russia Amifampridine Market Size, 2017-2028
6.5.8 Nordic Countries Amifampridine Market Size, 2017-2028
6.5.9 Benelux Amifampridine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Amifampridine Revenue, 2017-2028
6.6.2 By Region - Asia Amifampridine Sales, 2017-2028
6.6.3 China Amifampridine Market Size, 2017-2028
6.6.4 Japan Amifampridine Market Size, 2017-2028
6.6.5 South Korea Amifampridine Market Size, 2017-2028
6.6.6 Southeast Asia Amifampridine Market Size, 2017-2028
6.6.7 India Amifampridine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Amifampridine Revenue, 2017-2028
6.7.2 By Country - South America Amifampridine Sales, 2017-2028
6.7.3 Brazil Amifampridine Market Size, 2017-2028
6.7.4 Argentina Amifampridine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Amifampridine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Amifampridine Sales, 2017-2028
6.8.3 Turkey Amifampridine Market Size, 2017-2028
6.8.4 Israel Amifampridine Market Size, 2017-2028
6.8.5 Saudi Arabia Amifampridine Market Size, 2017-2028
6.8.6 UAE Amifampridine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Jacobus Pharmaceutical
7.1.1 Jacobus Pharmaceutical Corporate Summary
7.1.2 Jacobus Pharmaceutical Business Overview
7.1.3 Jacobus Pharmaceutical Amifampridine Major Product Offerings
7.1.4 Jacobus Pharmaceutical Amifampridine Sales and Revenue in Global (2017-2022)
7.1.5 Jacobus Pharmaceutical Key News
7.2 Unichem
7.2.1 Unichem Corporate Summary
7.2.2 Unichem Business Overview
7.2.3 Unichem Amifampridine Major Product Offerings
7.2.4 Unichem Amifampridine Sales and Revenue in Global (2017-2022)
7.2.5 Unichem Key News
7.3 BioMarin Pharmaceutical
7.3.1 BioMarin Pharmaceutical Corporate Summary
7.3.2 BioMarin Pharmaceutical Business Overview
7.3.3 BioMarin Pharmaceutical Amifampridine Major Product Offerings
7.3.4 BioMarin Pharmaceutical Amifampridine Sales and Revenue in Global (2017-2022)
7.3.5 BioMarin Pharmaceutical Key News
7.4 Wockhardt
7.4.1 Wockhardt Corporate Summary
7.4.2 Wockhardt Business Overview
7.4.3 Wockhardt Amifampridine Major Product Offerings
7.4.4 Wockhardt Amifampridine Sales and Revenue in Global (2017-2022)
7.4.5 Wockhardt Key News
7.5 Glenmark Pharmaceuticals
7.5.1 Glenmark Pharmaceuticals Corporate Summary
7.5.2 Glenmark Pharmaceuticals Business Overview
7.5.3 Glenmark Pharmaceuticals Amifampridine Major Product Offerings
7.5.4 Glenmark Pharmaceuticals Amifampridine Sales and Revenue in Global (2017-2022)
7.5.5 Glenmark Pharmaceuticals Key News
7.6 Norris Pharm
7.6.1 Norris Pharm Corporate Summary
7.6.2 Norris Pharm Business Overview
7.6.3 Norris Pharm Amifampridine Major Product Offerings
7.6.4 Norris Pharm Amifampridine Sales and Revenue in Global (2017-2022)
7.6.5 Norris Pharm Key News
7.7 BLD Pharm
7.7.1 BLD Pharm Corporate Summary
7.7.2 BLD Pharm Business Overview
7.7.3 BLD Pharm Amifampridine Major Product Offerings
7.7.4 BLD Pharm Amifampridine Sales and Revenue in Global (2017-2022)
7.7.5 BLD Pharm Key News
7.8 Biosynth AG
7.8.1 Biosynth AG Corporate Summary
7.8.2 Biosynth AG Business Overview
7.8.3 Biosynth AG Amifampridine Major Product Offerings
7.8.4 Biosynth AG Amifampridine Sales and Revenue in Global (2017-2022)
7.8.5 Biosynth AG Key News
7.9 Innovapharm
7.9.1 Innovapharm Corporate Summary
7.9.2 Innovapharm Business Overview
7.9.3 Innovapharm Amifampridine Major Product Offerings
7.9.4 Innovapharm Amifampridine Sales and Revenue in Global (2017-2022)
7.9.5 Innovapharm Key News
7.10 Founder Pharma
7.10.1 Founder Pharma Corporate Summary
7.10.2 Founder Pharma Business Overview
7.10.3 Founder Pharma Amifampridine Major Product Offerings
7.10.4 Founder Pharma Amifampridine Sales and Revenue in Global (2017-2022)
7.10.5 Founder Pharma Key News
7.11 BroadPharm
7.11.1 BroadPharm Corporate Summary
7.11.2 BroadPharm Amifampridine Business Overview
7.11.3 BroadPharm Amifampridine Major Product Offerings
7.11.4 BroadPharm Amifampridine Sales and Revenue in Global (2017-2022)
7.11.5 BroadPharm Key News
7.12 CSNpharm
7.12.1 CSNpharm Corporate Summary
7.12.2 CSNpharm Amifampridine Business Overview
7.12.3 CSNpharm Amifampridine Major Product Offerings
7.12.4 CSNpharm Amifampridine Sales and Revenue in Global (2017-2022)
7.12.5 CSNpharm Key News
7.13 Merck
7.13.1 Merck Corporate Summary
7.13.2 Merck Amifampridine Business Overview
7.13.3 Merck Amifampridine Major Product Offerings
7.13.4 Merck Amifampridine Sales and Revenue in Global (2017-2022)
7.13.5 Merck Key News
8 GLOBAL AMIFAMPRIDINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Amifampridine Production Capacity, 2017-2028
8.2 Amifampridine Production Capacity of Key Manufacturers in Global Market
8.3 Global Amifampridine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 AMIFAMPRIDINE SUPPLY CHAIN ANALYSIS
10.1 Amifampridine Industry Value Chain
10.2 Amifampridine Upstream Market
10.3 Amifampridine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Amifampridine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Amifampridine in Global Market
Table 2. Top Amifampridine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Amifampridine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Amifampridine Revenue Share by Companies, 2017-2022
Table 5. Global Amifampridine Sales by Companies, (K Units), 2017-2022
Table 6. Global Amifampridine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Amifampridine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Amifampridine Product Type
Table 9. List of Global Tier 1 Amifampridine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Amifampridine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Amifampridine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Amifampridine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Amifampridine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Amifampridine Sales (K Units), 2017-2022
Table 15. By Type - Global Amifampridine Sales (K Units), 2023-2028
Table 16. By Application – Global Amifampridine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Amifampridine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Amifampridine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Amifampridine Sales (K Units), 2017-2022
Table 20. By Application - Global Amifampridine Sales (K Units), 2023-2028
Table 21. By Region – Global Amifampridine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Amifampridine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Amifampridine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Amifampridine Sales (K Units), 2017-2022
Table 25. By Region - Global Amifampridine Sales (K Units), 2023-2028
Table 26. By Country - North America Amifampridine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Amifampridine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Amifampridine Sales, (K Units), 2017-2022
Table 29. By Country - North America Amifampridine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Amifampridine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Amifampridine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Amifampridine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Amifampridine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Amifampridine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Amifampridine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Amifampridine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Amifampridine Sales, (K Units), 2023-2028
Table 38. By Country - South America Amifampridine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Amifampridine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Amifampridine Sales, (K Units), 2017-2022
Table 41. By Country - South America Amifampridine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Amifampridine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Amifampridine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Amifampridine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Amifampridine Sales, (K Units), 2023-2028
Table 46. Jacobus Pharmaceutical Corporate Summary
Table 47. Jacobus Pharmaceutical Amifampridine Product Offerings
Table 48. Jacobus Pharmaceutical Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Unichem Corporate Summary
Table 50. Unichem Amifampridine Product Offerings
Table 51. Unichem Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. BioMarin Pharmaceutical Corporate Summary
Table 53. BioMarin Pharmaceutical Amifampridine Product Offerings
Table 54. BioMarin Pharmaceutical Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Wockhardt Corporate Summary
Table 56. Wockhardt Amifampridine Product Offerings
Table 57. Wockhardt Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Glenmark Pharmaceuticals Corporate Summary
Table 59. Glenmark Pharmaceuticals Amifampridine Product Offerings
Table 60. Glenmark Pharmaceuticals Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Norris Pharm Corporate Summary
Table 62. Norris Pharm Amifampridine Product Offerings
Table 63. Norris Pharm Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. BLD Pharm Corporate Summary
Table 65. BLD Pharm Amifampridine Product Offerings
Table 66. BLD Pharm Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Biosynth AG Corporate Summary
Table 68. Biosynth AG Amifampridine Product Offerings
Table 69. Biosynth AG Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Innovapharm Corporate Summary
Table 71. Innovapharm Amifampridine Product Offerings
Table 72. Innovapharm Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Founder Pharma Corporate Summary
Table 74. Founder Pharma Amifampridine Product Offerings
Table 75. Founder Pharma Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. BroadPharm Corporate Summary
Table 77. BroadPharm Amifampridine Product Offerings
Table 78. BroadPharm Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. CSNpharm Corporate Summary
Table 80. CSNpharm Amifampridine Product Offerings
Table 81. CSNpharm Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Merck Corporate Summary
Table 83. Merck Amifampridine Product Offerings
Table 84. Merck Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Amifampridine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Amifampridine Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Amifampridine Production by Region, 2017-2022 (K Units)
Table 88. Global Amifampridine Production by Region, 2023-2028 (K Units)
Table 89. Amifampridine Market Opportunities & Trends in Global Market
Table 90. Amifampridine Market Drivers in Global Market
Table 91. Amifampridine Market Restraints in Global Market
Table 92. Amifampridine Raw Materials
Table 93. Amifampridine Raw Materials Suppliers in Global Market
Table 94. Typical Amifampridine Downstream
Table 95. Amifampridine Downstream Clients in Global Market
Table 96. Amifampridine Distributors and Sales Agents in Global Market
Table 1. Key Players of Amifampridine in Global Market
Table 2. Top Amifampridine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Amifampridine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Amifampridine Revenue Share by Companies, 2017-2022
Table 5. Global Amifampridine Sales by Companies, (K Units), 2017-2022
Table 6. Global Amifampridine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Amifampridine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Amifampridine Product Type
Table 9. List of Global Tier 1 Amifampridine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Amifampridine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Amifampridine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Amifampridine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Amifampridine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Amifampridine Sales (K Units), 2017-2022
Table 15. By Type - Global Amifampridine Sales (K Units), 2023-2028
Table 16. By Application – Global Amifampridine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Amifampridine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Amifampridine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Amifampridine Sales (K Units), 2017-2022
Table 20. By Application - Global Amifampridine Sales (K Units), 2023-2028
Table 21. By Region – Global Amifampridine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Amifampridine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Amifampridine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Amifampridine Sales (K Units), 2017-2022
Table 25. By Region - Global Amifampridine Sales (K Units), 2023-2028
Table 26. By Country - North America Amifampridine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Amifampridine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Amifampridine Sales, (K Units), 2017-2022
Table 29. By Country - North America Amifampridine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Amifampridine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Amifampridine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Amifampridine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Amifampridine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Amifampridine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Amifampridine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Amifampridine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Amifampridine Sales, (K Units), 2023-2028
Table 38. By Country - South America Amifampridine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Amifampridine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Amifampridine Sales, (K Units), 2017-2022
Table 41. By Country - South America Amifampridine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Amifampridine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Amifampridine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Amifampridine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Amifampridine Sales, (K Units), 2023-2028
Table 46. Jacobus Pharmaceutical Corporate Summary
Table 47. Jacobus Pharmaceutical Amifampridine Product Offerings
Table 48. Jacobus Pharmaceutical Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Unichem Corporate Summary
Table 50. Unichem Amifampridine Product Offerings
Table 51. Unichem Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. BioMarin Pharmaceutical Corporate Summary
Table 53. BioMarin Pharmaceutical Amifampridine Product Offerings
Table 54. BioMarin Pharmaceutical Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Wockhardt Corporate Summary
Table 56. Wockhardt Amifampridine Product Offerings
Table 57. Wockhardt Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Glenmark Pharmaceuticals Corporate Summary
Table 59. Glenmark Pharmaceuticals Amifampridine Product Offerings
Table 60. Glenmark Pharmaceuticals Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Norris Pharm Corporate Summary
Table 62. Norris Pharm Amifampridine Product Offerings
Table 63. Norris Pharm Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. BLD Pharm Corporate Summary
Table 65. BLD Pharm Amifampridine Product Offerings
Table 66. BLD Pharm Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Biosynth AG Corporate Summary
Table 68. Biosynth AG Amifampridine Product Offerings
Table 69. Biosynth AG Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Innovapharm Corporate Summary
Table 71. Innovapharm Amifampridine Product Offerings
Table 72. Innovapharm Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Founder Pharma Corporate Summary
Table 74. Founder Pharma Amifampridine Product Offerings
Table 75. Founder Pharma Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. BroadPharm Corporate Summary
Table 77. BroadPharm Amifampridine Product Offerings
Table 78. BroadPharm Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. CSNpharm Corporate Summary
Table 80. CSNpharm Amifampridine Product Offerings
Table 81. CSNpharm Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Merck Corporate Summary
Table 83. Merck Amifampridine Product Offerings
Table 84. Merck Amifampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Amifampridine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Amifampridine Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Amifampridine Production by Region, 2017-2022 (K Units)
Table 88. Global Amifampridine Production by Region, 2023-2028 (K Units)
Table 89. Amifampridine Market Opportunities & Trends in Global Market
Table 90. Amifampridine Market Drivers in Global Market
Table 91. Amifampridine Market Restraints in Global Market
Table 92. Amifampridine Raw Materials
Table 93. Amifampridine Raw Materials Suppliers in Global Market
Table 94. Typical Amifampridine Downstream
Table 95. Amifampridine Downstream Clients in Global Market
Table 96. Amifampridine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Amifampridine Segment by Type
Figure 2. Amifampridine Segment by Application
Figure 3. Global Amifampridine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Amifampridine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Amifampridine Revenue, 2017-2028 (US$, Mn)
Figure 7. Amifampridine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Amifampridine Revenue in 2021
Figure 9. By Type - Global Amifampridine Sales Market Share, 2017-2028
Figure 10. By Type - Global Amifampridine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Amifampridine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Amifampridine Sales Market Share, 2017-2028
Figure 13. By Application - Global Amifampridine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Amifampridine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Amifampridine Sales Market Share, 2017-2028
Figure 16. By Region - Global Amifampridine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Amifampridine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Amifampridine Sales Market Share, 2017-2028
Figure 19. US Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Amifampridine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Amifampridine Sales Market Share, 2017-2028
Figure 24. Germany Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 25. France Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Amifampridine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Amifampridine Sales Market Share, 2017-2028
Figure 33. China Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 37. India Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Amifampridine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Amifampridine Sales Market Share, 2017-2028
Figure 40. Brazil Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Amifampridine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Amifampridine Sales Market Share, 2017-2028
Figure 44. Turkey Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Amifampridine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Amifampridine by Region, 2021 VS 2028
Figure 50. Amifampridine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Amifampridine Segment by Type
Figure 2. Amifampridine Segment by Application
Figure 3. Global Amifampridine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Amifampridine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Amifampridine Revenue, 2017-2028 (US$, Mn)
Figure 7. Amifampridine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Amifampridine Revenue in 2021
Figure 9. By Type - Global Amifampridine Sales Market Share, 2017-2028
Figure 10. By Type - Global Amifampridine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Amifampridine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Amifampridine Sales Market Share, 2017-2028
Figure 13. By Application - Global Amifampridine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Amifampridine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Amifampridine Sales Market Share, 2017-2028
Figure 16. By Region - Global Amifampridine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Amifampridine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Amifampridine Sales Market Share, 2017-2028
Figure 19. US Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Amifampridine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Amifampridine Sales Market Share, 2017-2028
Figure 24. Germany Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 25. France Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Amifampridine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Amifampridine Sales Market Share, 2017-2028
Figure 33. China Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 37. India Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Amifampridine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Amifampridine Sales Market Share, 2017-2028
Figure 40. Brazil Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Amifampridine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Amifampridine Sales Market Share, 2017-2028
Figure 44. Turkey Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Amifampridine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Amifampridine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Amifampridine by Region, 2021 VS 2028
Figure 50. Amifampridine Industry Value Chain
Figure 51. Marketing Channels
